Cargando…
IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
Influenza A virus (IAV)‐induced severe disease is characterized by infected lung epithelia, robust inflammatory responses and acute lung injury. Since type I interferon (IFNαβ) and type III interferon (IFNλ) are potent antiviral cytokines with immunomodulatory potential, we assessed their efficacy a...
Autores principales: | Davidson, Sophia, McCabe, Teresa M, Crotta, Stefania, Gad, Hans Henrik, Hessel, Edith M, Beinke, Soren, Hartmann, Rune, Wack, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009813/ https://www.ncbi.nlm.nih.gov/pubmed/27520969 http://dx.doi.org/10.15252/emmm.201606413 |
Ejemplares similares
-
Pathogenic potential of interferon αβ in acute influenza infection
por: Davidson, Sophia, et al.
Publicado: (2014) -
IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission
por: Klinkhammer, Jonas, et al.
Publicado: (2018) -
Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection
por: Aegerter, Helena, et al.
Publicado: (2020) -
IFNλ: balancing the light and dark side in pulmonary infection
por: Antos, Danielle, et al.
Publicado: (2023) -
Zinc is a potent and specific inhibitor of IFN-λ3 signalling
por: Read, Scott A., et al.
Publicado: (2017)